LeMaitre to Participate at Upcoming Investor Conferences in March

LeMaitre Vascular, Inc. (Nasdaq:LMAT) will participate in four investor conferences in March 2023.

Rhea-AI Summary

LeMaitre Vascular, Inc. (Nasdaq:LMAT) will participate in four investor conferences in March 2023. Key events include the 35th Annual Roth Conference on March 13, featuring President David Roberts in a fireside chat at 12:30 PM PT. On March 15, the Oppenheimer 33rd Annual Healthcare Conference will feature CFO JJ Pellegrino at 8:40 AM ET, followed by Roberts presenting at the Barclays Global Healthcare Conference at 2:35 PM ET. Finally, on March 22, Roberts will present at the KeyBanc Life Sciences & MedTech Investor Forum at 3:00 PM ET. LeMaitre provides innovative devices for peripheral vascular disease, serving a global market of over 200 million patients.

Argus Session date unavailable

-0.43% session move Open Argus

Details

News Market Reaction – LMAT

The recorded move for LMAT in the trading session of this news was -0.43%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BURLINGTON, Mass., March 03, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four upcoming investor conferences in March.

35th Annual Roth Conference 2023
Monday, March 13, 2023
The Ritz Carlton, Laguna Niguel located in Dana Point, CA
David Roberts, President, will participate in a fireside chat at 12:30 PM PT (3:30 PM ET)

Oppenheimer 33rd Annual Healthcare Conference (Virtual)
Wednesday, March 15, 2023
JJ Pellegrino, Chief Financial Officer, will present at 8:40 AM ET

Barclays Global Healthcare Conference
Wednesday, March 15, 2023
Loews Miami Beach Hotel, Miami Beach, FL
David Roberts, President, will present at 2:35 PM ET

KeyBanc Life Sciences & MedTech Investor Forum (Virtual)
Wednesday, March 22, 2023
David Roberts, President, will present at 3:00 PM ET

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What conferences will LeMaitre Vascular (LMAT) attend in March 2023?

LeMaitre Vascular will participate in four conferences: the 35th Annual Roth Conference on March 13, Oppenheimer 33rd Annual Healthcare Conference on March 15, Barclays Global Healthcare Conference on March 15, and KeyBanc Life Sciences & MedTech Investor Forum on March 22.

Who is presenting for LeMaitre Vascular at the Roth Conference 2023?

David Roberts, the President of LeMaitre Vascular, will participate in a fireside chat at the 35th Annual Roth Conference on March 13, 2023.

What time is LeMaitre's presentation at the Oppenheimer Conference?

JJ Pellegrino, CFO of LeMaitre Vascular, will present at the Oppenheimer 33rd Annual Healthcare Conference at 8:40 AM ET on March 15, 2023.

When does LeMaitre Vascular have its presentation at the Barclays Conference?

David Roberts will present for LeMaitre Vascular at the Barclays Global Healthcare Conference at 2:35 PM ET on March 15, 2023.

What is LeMaitre Vascular known for?

LeMaitre Vascular specializes in devices and services for the treatment of peripheral vascular disease, impacting over 200 million people globally.